- Home
- / Orbis Medicines
Orbis Medicines
Total Funding
$26 M
Orbis Medicines Summary
Company Summary
- Overview
- Orbis Medicines is a company that develops a drug discovery platform. It focuses on developing oral macrocycle drug candidates.
- Type
- Private
- Status
- Active
- Founded
- 2021
- HQ
- Lausanne, CH | view all locations
- Cybersecurity rating
Table of Contents
Key People
Sevan Habeshian, Co-Founder and Chief Technology Officer
Daniela Brodbeck, VP, Discovery Biology
Daniel Greve, VP, Drug Discovery
LocationsView all
2 locations detected
Lausanne, VD HQ
Switzerland
Route de la Corniche 6
Copenhagen
Denmark